Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    21217178 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia
Condition: Staph Aureus Methicillin Resistant Bacteremia
Interventions: Drug: Fosfomycin 2gr/6h iv;   Drug: Daptomycin  10mg/kg/24h iv
2 Recruiting TR-701 FA vs Linezolid for the Treatment of Nosocomial Pneumonia
Condition: Pneumonia
Interventions: Drug: TR-701 FA IV;   Drug: Linezolid

Indicates status has not been verified in more than two years